Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?
Van Cutsem
Eric
E
Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. eric.vancutsem@uz.kuleuven.ac.be